Part D Enhanced Plans With Gap Coverage For Generics Increasing For 2011
The number of enhanced stand-alone Medicare Part D plans offering to pay for generic drugs in the coverage gap will grow from 321 plans in 2010 to 341 plans in 2011, according to a preview of next year’s Part D landscape released by the Centers for Medicare and Medicaid Services Sept. 21.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
In the report accompanying FY 2023 HHS appropriations legislation, the House committee also addresses biosimilar uptake in Part D, Medicare dispensing fees for oral COVID-19 drugs and NIH grants for expanded access to investigational ALS drugs.
US legislation attempts to address manufacturer, pharmacy benefit manager impact on patient costs in addition to health plan benefit designs. Critics suggest it’s too easy on manufacturers but that may help its chances with Republicans.